Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phosphoribosyl pyrophosphate synthetase pseudogene is a genetic element similar in sequence to the protein-coding PRPS genes, but is classified as a pseudogene, meaning it does not encode a functional protein and is not expressed as an active enzyme. Pseudogenes are remnants of once-functional genes that have lost their protein-coding ability or are otherwise non-functional due to mutations. This pseudogene does not contribute to cellular metabolism or disease processes directly. Its functional relatives, such as PRPS1 and PRPS2, are enzymes involved in nucleotide biosynthesis and purine metabolism, but the pseudogene itself has no independent biological or clinical significance as a drug target[7]. Note: If your intent was to inquire about the active phosphoribosyl pyrophosphate synthetase, the canonical gene is PRPS1 (phosphoribosyl pyrophosphate synthetase 1), which is an actual metabolic enzyme and known disease gene[2][3][6]. The presented Ensembl ID points to a pseudogene, which should not be considered a protein-coding therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoribosyl pyrophosphate synthetase pseudogene.